These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36160903)
1. Cocktail therapy with prednisolone, vincristine and sirolimus for Kasabach‑Merritt phenomenon in 10 infants. Liu Q; Xiong N; Gong X; Tong H; Tan X; Guo X Exp Ther Med; 2022 Oct; 24(4):621. PubMed ID: 36160903 [TBL] [Abstract][Full Text] [Related]
2. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. Cashell J; Smink GM; Helm K; Xavier F Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028 [TBL] [Abstract][Full Text] [Related]
3. Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial. Ji Y; Chen S; Zhou J; Yang K; Zhang X; Xiang B; Qiu T; Gong X; Zhang Z; Lan Y; Hu F; Kong F; Qiu Q; Zhang Y Blood; 2022 Mar; 139(11):1619-1630. PubMed ID: 35030255 [TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon in an infant girl. Helligsø L; Mikkelsen TS; Hvas AM Clin Case Rep; 2023 Sep; 11(9):e7859. PubMed ID: 37720715 [TBL] [Abstract][Full Text] [Related]
5. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study. Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787 [TBL] [Abstract][Full Text] [Related]
6. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262 [TBL] [Abstract][Full Text] [Related]
7. The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon. Vivas-Colmenares GV; Ramirez-Villar GL; Bernabeu-Wittel J; Matute de Cardenas JA; Fernandez-Pineda I Dermatol Pract Concept; 2015 Jan; 5(1):91-3. PubMed ID: 25692091 [TBL] [Abstract][Full Text] [Related]
8. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options. Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848 [TBL] [Abstract][Full Text] [Related]
9. Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma. Wang L; Li J; Wu C; Song D; Liu Z; Niu Y; Zhou J; Guo L Front Pediatr; 2022; 10():949950. PubMed ID: 35990005 [TBL] [Abstract][Full Text] [Related]
10. Sirolimus monotherapy for Kasabach-Merritt phenomenon in a neonate; Case report. Nakamura S; Ozeki M; Hayashi D; Yasue S; Endo S; Ohnishi H Int J Surg Case Rep; 2024 Apr; 117():109497. PubMed ID: 38518465 [TBL] [Abstract][Full Text] [Related]
11. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options. Mahajan P; Margolin J; Iacobas I Clin Med Insights Blood Disord; 2017; 10():1179545X17699849. PubMed ID: 28579853 [TBL] [Abstract][Full Text] [Related]
12. Successful management of steroid-resistant vascular tumors associated with the Kasabach-Merritt phenomenon using sirolimus. Tan X; Zhang J; Zhou S; Liu Z; Zhang T; Xia J J Dermatol; 2018 May; 45(5):580-583. PubMed ID: 29356076 [TBL] [Abstract][Full Text] [Related]
13. Sirolimus for Vincristine-Resistant Kasabach-Merritt Phenomenon: Report of Eight Patients. Wang H; Duan Y; Gao Y; Guo X Pediatr Dermatol; 2017 May; 34(3):261-265. PubMed ID: 28198567 [TBL] [Abstract][Full Text] [Related]
14. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma. Peng S; Yang K; Xu Z; Chen S; Ji Y J Paediatr Child Health; 2019 Sep; 55(9):1119-1124. PubMed ID: 30604513 [TBL] [Abstract][Full Text] [Related]
15. [Refractory kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: clinical analysis of 10 cases]. Zhang GL; Gao Y; Liu Y; Gu F; Su W; Qin Q; Chen JY; Zhang HH; Yang J; Liu XY Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):700-704. PubMed ID: 28881518 [No Abstract] [Full Text] [Related]
16. Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature. Yuan SM; Shen WM; Chen HN; Hong ZJ; Jiang HQ Int J Clin Exp Med; 2015; 8(6):10006-10. PubMed ID: 26309243 [TBL] [Abstract][Full Text] [Related]
17. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma. Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291 [TBL] [Abstract][Full Text] [Related]
18. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants. Wang Y; Kong L; Sun B; Cui J; Shen W J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003 [TBL] [Abstract][Full Text] [Related]
19. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon. Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442 [TBL] [Abstract][Full Text] [Related]
20. Refractory Kasabach-Merritt phenomenon successfully treated with sirolimus, and a mini-review of the published work. Wang Z; Li K; Dong K; Xiao X; Zheng S J Dermatol; 2015 Apr; 42(4):401-4. PubMed ID: 25728547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]